University of Illinois
Chicago, Illinois, 60612, United States
NCT Number: NCT05920850
This study is a single-arm pre-test post-test design with a two-month follow-up assessment. The study aims to provide support to participants in quitting smoking and accessing lung cancer screening through the combination of education interventions and patient navigation (PN)
Looking for future studies?
Notify Me50 year–80 year
Male
Interventional
Not applicable
Chicago, Illinois, 60612, United States
This study is a single-arm pre-test post-test design with a two-month follow-up assessment. The study aims to provide support to participants in quitting smoking and accessing lung cancer screening through the combination of education interventions and patient navigation (PN). After participant consent the study team will administer a series of surveys to collect the participant's contact information and complete the study's pretest measures. These include a demographic survey, smoking history, lung cancer knowledge, lung screening knowledge, intention to quit/screen, informed to decide, satisfaction survey, and decision conflict survey. The study also consists of three scheduled meetings with the PN lasting up to 60 minutes. The 1st session will be held between 7-14 days after consent. The 2nd session will be held 7-14 after the 1st session and the 3rd session will be held 42-49 days after the 1st session. Additional phone calls will last 10 minutes or less and be focused on specific questions generated by study participants.
In the 1st session the PN will re-orient participant to the goals and objectives of the project and answer participant questions before starting the intervention. The 1st activity will be to show a 3 minute culturally tailored video that will explain the benefits of lung cancer screening for African American Males (AAM) using an internet-enabled device. After completion of the video, the PN will invite the participant to ask any questions that they have and the PN will offer clarifying information. The PN will review with the participant a culturally adapted shared decision-making tool. The participant will complete the posttest surveys as described abov.
In the 2nd session the PN will determine the scheduling and completion of lung cancer screening and Illinois Tobacco Quit Line (ITQL) engagement. The participant will complete the LDCT screening, navigation needs, Quitline Engagement, and decision change surveys
In the 3rd session the PN will determine scheduling, barriers and completion of lung cancer screening and Quitline engagement. The participant will complete LDCT screening check, and a Quitline engagement check
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A culturally tailored video that provides education about the process LDCT lung cancer screening
A culturally tailored shared decision-making tool that educates participants about the shared decision-making process
The use of a flip chart that reinforces the information provided in the video and shared decision-making tool
Navigation support for participants who express interest in LDCT and quitting smoking.
Time frame: 1 year
Number of participants that show an improvement from pretest to posttest
Time frame: 1 year
Number of participants that complete lung cancer screening
Time frame: 1 year
Number of participants that completed the referral to smoking cessation treatment to the ITQL
University of Illinois at Chicago
Other
The SHARED Project (Testing a Lung Cancer Screening Intervention for AAM)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02914899
Current or Past Cigarette Smoker, Lung Cancer Screening
New York, United States
View Trial DetailsNCT05645731
Behavior, Health Behavior
Montreal, Quebec, Canada
View Trial DetailsNCT07052773
Lung Cancer Screening
Tel Aviv, Israel
View Trial DetailsNCT03069924
Behavior, Health Behavior
New Haven, Connecticut, United States
View Trial Details